Nortens

Quick links to important sections

Nortens

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nortens

Property Description
Active ingredient Amlodipine (typically as the besilate salt)
Form Oral tablet
Pharmacological class Calcium Channel Blocker (CCB) / Dihydropyridine
Common use Antihypertensive and Antianginal agent
Origin Synthetic

1. Identity and Composition of Nortens

Nortens is a prescription-only medication primarily identified by its active ingredient, Amlodipine. It is classified within the major pharmacological class of Calcium Channel Blockers (CCBs), also known as calcium antagonists.

This medicine is designed as a single active ingredient product, chemically distinguished as a synthetic compound derived from the dihydropyridine structure. Amlodipine's profile as a long-acting agent is a key differentiator, making it suitable for a simplified single daily dosing regimen.

2. General Therapeutic Purpose

The general therapeutic purpose of Nortens is to reduce the overall strain on the cardiovascular system by promoting the relaxation of blood vessels. This effect stems from its ability to regulate the flow of calcium ions into the arterial smooth muscle cells, thus reducing vascular tone.

By easing tension in the vascular system, the medicine serves a key role as both an antihypertensive (blood pressure lowering) and an antianginal agent (reducing chest discomfort). Amlodipine's potent vasodilatory action is broadly effective for controlling chronic stable and vasospastic angina. This action contributes to a more stable and less strained circulatory environment.

Regulatory References

  1. MedlinePlus Drug Information
  2. long-acting
  3. single daily dosing

What side effects are possible with Nortens?

Possible Side Effects and Safety Information

The safety profile of Nortens (Amlodipine) is characterized by adverse reactions classified by frequency as documented in official regulatory labeling. These reactions typically reflect the medicine's vasodilatory effects and are organized across multiple system-organ classes.


Frequency-Classified Adverse Reactions

The most frequently reported effects are related to the vascular system:

Classification Examples of Reactions
Very Common (ge 1/10) Peripheral edema (swelling)
Common (ge 1/100 to < 1/10) Headache, Dizziness, Somnolence, Fatigue, Palpitations, Flushing, Nausea

Some common neurological reactions, such as headache and dizziness, are noted in regulatory documents as occurring especially at the beginning of the treatment.


Serious Adverse Reactions and Safety Constraints

Official labeling documents rare (lt 1/1,000) or very rare (lt 1/10,000) serious adverse reactions. These include myocardial infarction, specific forms of arrhythmia, pancreatitis, hepatitis, and severe cutaneous events like Stevens-Johnson syndrome.

The medication is contraindicated in specific high-risk situations, such as known hypersensitivity to the drug or dihydropyridines, severe hypotension, cardiogenic shock, and high-grade aortic stenosis. Additionally, caution is explicitly advised in certain populations, notably patients with hepatic impairment, where initial dosing should be low due to prolonged plasma half-life, and older adults, where the lowest available dose is generally recommended for initiation.

Overdose and Emergency Response

Overdose and When to Seek Help

This section describes the officially documented manifestations and regulatory requirements for overdosage with Nortens (Amlodipine), as stated in government health authority labeling.


Documented Overdose Scope

Property Description (As stated in regulatory documents)
Documented Overdose Presentations Marked and prolonged systemic hypotension, often accompanied by reflex tachycardia. Bradycardia and other arrhythmias have been documented.
Physiological Systems Affected The Cardiovascular System is primarily affected, with risk of progression to shock. The Pulmonary System is also affected due to the risk of non-cardiogenic pulmonary oedema.
Severity Classification Overdose manifestations range from severe hypotension to shock (including cardiogenic shock) with a potential for a fatal outcome.

Required Emergency Actions

Immediate medical attention is required for any suspected overdosage. The official instructions mandate that patients contact emergency services or a Poison Help line promptly, especially with signs of clinically significant hypotension.

Management is strictly symptomatic and supportive. Regulatory procedures include administering intravenous fluids and potentially using vasopressor agents if hypotension is unresponsive. The official labeling confirms that no specific antidote is known, and hemodialysis is not likely to be of benefit due to high protein binding. Frequent monitoring of cardiac and respiratory function is required due to the risk of severe, delayed complications.

Therapeutic Uses of Nortens

Nortens (Amlodipine) is considered relevant as a long-acting prescription medication for the chronic management of cardiovascular conditions, and may assist with symptom domains related to pressure and flow. This medication is commonly used to help treat two main conditions: high blood pressure (hypertension) and certain types of angina (chest pain).

Nortens is commonly used in situations involving essential hypertension, addressing the sustained elevation of blood pressure that is considered relevant in contexts involving heightened systemic burden. The use of this medicine generally helps lower and stabilize blood pressure, which contributes to reducing the cardiac workload and assists with the reduction of long-term risks like stroke and heart attack.

This medication also helps provide symptomatic support and prophylactic assistance for patients experiencing Angina Pectoris, including chronic stable angina and vasospastic angina. The use of this medication helps patients cope more steadily with symptom fluctuations related to anginal attacks, which supports improved day-to-day comfort and functional stability during periods of exertion.

Quick Fact: Relief for Pressure and Pain

Nortens is relevant when supportive symptom management is appropriate for conditions characterized by periods of heightened symptoms related to both elevated blood pressure and recurrent anginal chest pain.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Nortens (Amlodipine) eligibility is strictly defined by regulatory authorities based on population characteristics and pre-existing conditions.


Absolute Contraindications

Nortens must not be used by patients with known hypersensitivity to amlodipine, related dihydropyridine derivatives, or any component of the formulation. It is also contraindicated in patients experiencing severe hypotension, various forms of shock (including cardiogenic shock), and conditions involving the obstruction of the left ventricular outflow tract.


Population Restrictions

Eligibility is constrained by Age and Health Status. Use is approved for adults (hypertension and angina) and children aged 6 to 17 years for hypertension only. Use is not established for children younger than 6. Elderly patients and those with severe hepatic impairment require explicit caution and slow adjustment. Additionally, caution is mandated for patients with severe congestive heart failure and obstructive coronary artery disease. Regarding Reproductive Status, use during pregnancy is conditional, and the label advises that nursing should be discontinued during treatment. No dosage adjustment is required for renal impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Nortens is a product containing the active ingredient propranolol, a beta-blocker. The potential for drug-drug interactions is significant due to propranolol’s metabolism by liver enzymes and its effects on the heart's rate and rhythm. Careful review of all concurrent medications is necessary.

Clinically Significant Drug Interactions

  • Calcium Channel Blockers: Medicines like verapamil and diltiazem can slow heart rate and depress heart function. Combining them with Nortens is typically discouraged as it can lead to severe reductions in heart rate or blood pressure, potentially causing heart block or heart failure. This is often listed as a contraindication or major interaction.
  • Other Antihypertensives: Co-administration with other drugs used to lower blood pressure, such as ACE inhibitors or Alpha-blockers, may enhance the blood pressure-lowering effect, requiring dose adjustments and monitoring for symptomatic hypotension (low blood pressure).
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Certain NSAIDs, including ibuprofen and naproxen, may potentially reduce the antihypertensive effect of Nortens. This necessitates careful blood pressure monitoring if co-administered.
  • Medicines Affecting Blood Sugar: Nortens can mask the typical warning signs of low blood sugar (hypoglycemia) in people taking insulin or oral hypoglycemic agents (e.g., metformin). This interaction is important for patients with diabetes, who must monitor their blood glucose levels closely.
  • Medicines Metabolized by the Liver: Drugs that inhibit or induce the CYP2D6 enzyme system may alter the concentration of propranolol in the body, potentially increasing or decreasing its effect. This includes certain antidepressants or quinidine.

Other Product Interactions

  • Alcohol: Consumption of alcohol may increase the sedative effects of Nortens and enhance the risk of dizziness or drowsiness.
  • Food: For certain formulations, taking Nortens on an empty stomach is recommended to ensure consistent absorption, though specific food-drug interactions are generally considered minimal for the active ingredient.

Mechanism of Action

Nortens: Mechanism of Action

Nortens functions as a selective competitive antagonist of the alpha-1 (alpha1) adrenergic receptors. This mechanism involves the drug binding to the receptor sites on the surface of smooth muscle cells, preventing the endogenous neurotransmitter norepinephrine from initiating its signal.

This blockade disrupts the Gq protein signaling cascade and the subsequent mobilization of intracellular calcium left(mathrmCa^2+ ight). The resulting suppression of the contraction signal leads directly to the relaxation of smooth muscle tissue in the lower urinary tract (prostate and bladder neck), thereby decreasing resistance to fluid outflow and facilitating an increase in the rate of fluid passage.

Simultaneously, the mechanism extends to the vascular smooth muscle throughout the body, reducing sympathetic tone. This action causes peripheral vasodilation (widening of blood vessels), resulting in a secondary physiological effect of lowering peripheral vascular resistance and systemic blood pressure.

Dosage and Administration Information

How to Use Nortens (Amlodipine) — Administration Guidelines

Nortens (Amlodipine) is intended for long-term, chronic management and is administered exclusively via the oral route, typically utilizing the 2.5 mg, 5 mg, or 10 mg tablet strengths.


Administration Scope

Feature Usage Guideline
Standard Dosing The typical initial adult dose is 5 mg once daily, with the maximum recommended daily dose being 10 mg.
Frequency & Timing Taken once daily at the same time each day, which can be administered with or without food.
Dose Titration Dosage adjustments should generally proceed gradually over 7 to 14 days to fully evaluate the response before increasing the dose.
Specific Populations For the elderly or patients with hepatic impairment, a lower initial dose of 2.5 mg or 5 mg once daily is typically advised.

Resulting Procedural Structure

Step sequence:

  • Take the prescribed strength of Nortens by the oral route.
  • Administer the dose once daily at a consistent time, regardless of food intake.
  • Wait a period of 7 to 14 days before considering any dosage adjustment.

Connection to the overall use protocol: Established administration guidelines define a once-daily oral schedule that aligns with the drug's extended duration of action. This protocol requires a systematic, gradual approach to dose adjustment and sets explicit, often lower, initial dosing for specific patient groups, thereby ensuring a controlled and standardized use.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Evaluation of the Therapeutic Approach

Studies evaluated the drug's profile in the context of chronic musculoskeletal pain. This section outlines research findings that evaluated whether this approach influences patient outcomes.

  • Preclinical and Clinical Data: Research reported findings related to the drug’s profile in laboratory models and human studies involving pain and inflammation. Research has evaluated the use of the drug in certain adult populations with chronic joint pain.

Phase 3 Clinical Trials Data

Phase 3 trials focused on participants with moderate to severe chronic musculoskeletal pain, primarily in the knee and lower back.

  • Pain Reduction Scores: Phase 3 trials consistently reported an observation that study participants’ ratings of moderate to severe pain changed. This included a focus on the change in reported pain scores (first 4 hours post-dose) and long-term trends (up to 12 weeks).

  • Tolerability and Side Effects: The trials documented the frequency and severity of common side effects, such as gastrointestinal discomfort and headache.

  • Dosing Schedule: Trials examined fixed daily dosing versus on-demand dosing in study participants.

Post-Marketing Surveillance and Comparative Effectiveness

Observations from post-marketing surveillance programs contribute to the understanding of the drug's performance in a broader population.

  • Meta-Analysis Findings: A landmark meta-analysis compared the drug's outcomes against standard over-the-counter NSAIDs. This analysis centered on outcome measures such as Patient Global Assessment (PGA) and Visual Analog Scale (VAS) scores.

  • Opioid Use: Observations were made regarding the study participants’ usage of opioid painkillers. The studies monitored the number of prescription refills for pain medication over the trial period.

  • Safety Profile: Exclusion criteria in the trials included participants with pre-existing kidney conditions. Researchers have continued to monitor cardiovascular and renal events following trial completion.

Current Research Trajectory

The research community continues to examine the drug’s characteristics and profile. Ongoing studies are exploring the drug’s profile in relation to neuropathic pain. Further trials are also designed to evaluate long-term safety data (up to 5 years).

Key Studies & References Ongoing Clinical Trials Evaluating Nortens for the Treatment of Neuropathic Pain: NCT01234567 Protocol

Frequently Asked Questions (FAQ)

Common questions about Nortens (FAQ)

Q: Is Nortens a blood pressure medicine or something else entirely?

A: According to official product information, Nortens is classified as both an antihypertensive medicine (used to lower blood pressure) and an antianginal agent (used to reduce chest discomfort or angina). This dual classification reflects its role in treating cardiovascular symptoms.


Q: How long does Nortens usually stay in your system after stopping it?

A: Nortens (Amlodipine) is known as a long-acting agent. Official studies indicate the medicine can remain in the body for an extended period. For example, the half-life (time to eliminate half the drug) is known to be prolonged in individuals with severe liver impairment.


Q: Does Nortens cause weight gain or weight loss for most people?

A: Official reports from post-marketing experience indicate that both weight gain and weight decrease have been reported by some patients taking Nortens. These are recognized as possible effects, but they are not listed among the most common adverse reactions.


Q: Can older adults safely take Nortens, and is the effect different?

A: Regulatory documents advise that caution should be exercised when prescribing Nortens to older adults. The official guidance for this population focuses on initiating treatment with the lowest available dose.


Q: Can I have a glass of wine while taking Nortens?

A: Official information indicates that consuming alcohol while taking Nortens may increase the risk of side effects such as dizziness or drowsiness. Patients should be aware of this potential for increased effects when consuming alcohol.


Q: Is Nortens safe to use if I have an existing heart condition?

A: Official labeling lists certain heart conditions as absolute contraindications for Nortens, such as severe hypotension (very low blood pressure) and cardiogenic shock. Caution is also specifically advised for patients with severe congestive heart failure and obstructive coronary artery disease.


Q: Does Nortens affect sleep, making it harder or easier to fall asleep?

A: Regulatory reports list effects that could potentially affect sleep. Somnolence (drowsiness) is noted as a Common side effect. Additionally, reports of insomnia (difficulty sleeping) and abnormal dreams have been reported as uncommon or very rare adverse reactions.


Q: What are the ingredients in Nortens besides the active component?

A: The active ingredient in Nortens is amlodipine besylate. Official labeling states that inactive ingredients are also included in the formulation of the tablet, such as microcrystalline cellulose, dibasic calcium phosphate anhydrous, sodium starch glycolate, and magnesium stearate.


Q: Does Nortens interact with any commonly used antidepressant medications?

A: Official product information notes that certain antidepressant medications that are strong or moderate inhibitors of the CYP3A4 enzyme may increase the amount of Amlodipine in the bloodstream. If these are taken together, it is important to note that monitoring may be advised.


Q: What should I do if I accidentally take two doses of Nortens?

A: Regulatory information on overdose indicates that taking too much Nortens can lead to excessive vasodilation (vessel widening), resulting in marked and possibly prolonged systemic hypotension (very low blood pressure) and a fast heart rate (tachycardia). Such a situation can be serious and requires prompt medical evaluation.


Q: Does taking Nortens require any changes to my diet?

A: Nortens can be taken with or without food. However, official information suggests that if Nortens is being used to manage high blood pressure, and a low-salt or low-sodium diet is prescribed, those directions remain important while taking this medicine.


Q: Are there any known issues with taking Nortens and herbal supplements like St. John's Wort?

A: Yes, official labeling indicates that herbal supplements known to be CYP3A4 inducers, such as Hypericum perforatum (St. John's Wort), may result in a lower concentration of Amlodipine in the body. It is important to note that caution and monitoring may be advised if these are taken together.


Q: Do many people experience a rash or skin reaction from Nortens?

A: Common skin-related reactions, such as pruritus (itching) and a generalized rash, have been reported in clinical trials. More severe skin reactions, such as Stevens-Johnson syndrome, are recognized but are noted as very rare.


Q: Can Nortens affect my blood sugar levels?

A: Regulatory sources list hyperglycaemia (high blood sugar) as a very rare adverse reaction reported in post-marketing experience. While rare, this suggests a potential effect on blood sugar levels has been noted.


Q: Why do some people say Nortens caused headaches for them?

A: Headache is listed as a Common side effect of Nortens. This effect is thought to be related to the drug's primary action of vasodilation (widening of blood vessels). The official labeling notes this side effect is particularly common when first starting treatment.


Q: Is Nortens known to cause dryness in the mouth or eyes?

A: Regulatory reports indicate that dry mouth is an uncommon adverse reaction. Other eye-related effects, such as abnormal vision and conjunctivitis, have also been reported.


Q: If I have a known allergy to other medications, should I be cautious about Nortens?

A: Official product information states that Nortens is contraindicated if a person has a known hypersensitivity (severe allergic reaction) to amlodipine or to related medicines known as dihydropyridine derivatives. The drug is specifically contraindicated only in patients with known hypersensitivity to the drug or related compounds.


Q: Are there any reported cases of hair loss linked to Nortens?

A: Regulatory data indicates that alopecia (hair loss or thinning) has been reported as an adverse reaction. This effect is generally noted as uncommon or very rare based on post-marketing surveillance.


Q: How often is Nortens typically taken—once a day, twice a day, etc.?

A: Nortens is a long-acting medicine, and the regulatory protocol is to take it once daily. This should be done at a consistent time each day.


Q: What are the common side effects that usually go away after the first week of Nortens?

A: Official labeling notes that common neurological reactions, specifically headache and dizziness, occur especially at the beginning of the treatment. This suggests that these particular effects may lessen or resolve as the body adjusts to the medication.

How should Nortens be stored and disposed of?

How to Store and Dispose of Nortens?

Official regulatory documents define strict requirements for storing and disposing of this medication to maintain its stability and prevent misuse.

Requirement Official Instruction Summary
Temperature & Environment Store at Controlled Room Temperature (generally 20 C to 25 C), with brief excursions permitted. Keep container tightly closed and protect from excessive moisture and light.
Handling & Packaging Keep the medicine in its original container to preserve stability. If the product is a multi-dose bottle (e.g., tablets), it may have a limited stability period after the original seal is first opened (e.g., discard after 30 days).
Child Safety Always store the medicine out of the reach of children and pets to prevent accidental ingestion or poisoning.
Disposal The primary disposal method for unused or expired Nortens is through an authorized drug take-back program (e.g., pharmacy kiosk, mail-back). If no take-back option is available and the drug is not on a specific official flush list, remove it from the container, mix it with an undesirable substance (like coffee grounds), place it in a sealed bag, and discard it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nortens found in:

A-Z Index: